AXSM (STOCKS)
Axsome Therapeutics, Inc
$213.680000
-0.980000 (-0.46%)
Prev close: $214.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Herriott Tabuteau
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11,384.72M
- Employees
- 816
- P/E (TTM)
- -57.10
- P/B (TTM)
- 134.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
16
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.99 | $-0.86 | -0.1284 | -14.90% |
|
Mar 2026 (Q1)
|
$-1.26 | $-0.91 | -0.3461 | -37.87% |
|
Dec 2025 (Q4)
|
$-0.56 | $-0.68 | +0.1226 | +17.96% |
|
Sep 2025 (Q3)
|
$-0.94 | $-0.88 | -0.0571 | -6.47% |
Financial Statements
| Revenues | $776.57M |
| Benefits Costs and Expenses | $967.66M |
| Costs And Expenses | $962.64M |
| Operating Expenses | $962.64M |
| Selling, General, and Administrative Expenses | $712.67M |
| Research and Development | $187.86M |
| Other Operating Expenses | $62.12M |
| Operating Income/Loss | -$186.07M |
| Income/Loss From Continuing Operations After Tax | -$191.64M |
| Income/Loss From Continuing Operations Before Tax | -$191.09M |
| Income Tax Expense/Benefit | $558.00K |
| Interest Expense, Operating | -$6.69M |
| Net Income/Loss | -$191.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$191.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$191.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.74 |
| Diluted Earnings Per Share | -$3.74 |
| Basic Average Shares | 101,820,499 |
| Diluted Average Shares | 101,820,499 |
| Assets | $761.45M |
| Current Assets | $656.57M |
| Inventory | $37.88M |
| Other Current Assets | $618.69M |
| Noncurrent Assets | $104.88M |
| Fixed Assets | $874.00K |
| Intangible Assets | $37.36M |
| Other Non-current Assets | $66.65M |
| Liabilities | $678.14M |
| Current Liabilities | $460.45M |
| Accounts Payable | $78.97M |
| Wages | $32.94M |
| Other Current Liabilities | $348.54M |
| Noncurrent Liabilities | $217.70M |
| Equity | $83.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $83.30M |
| Liabilities And Equity | $761.45M |
| Net Cash Flow From Operating Activities | -$71.26M |
| Net Cash Flow From Operating Activities, Continuing | -$71.26M |
| Net Cash Flow From Investing Activities | -$700.00K |
| Net Cash Flow From Investing Activities, Continuing | -$700.00K |
| Net Cash Flow From Financing Activities | $88.79M |
| Net Cash Flow From Financing Activities, Continuing | $88.79M |
| Net Cash Flow | $16.83M |
| Net Cash Flow, Continuing | $16.83M |
| Comprehensive Income/Loss | -$191.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$191.64M |
| Other Comprehensive Income/Loss | $0.00 |